Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A recent analysis indicated that many non-diabetic but overweight or obese semaglutide users discontinue their treatment after approximately two years
The drugs manufacturer reports one in three people on the 10mg or 15mg dose of Zepbound experienced a -25% change in weight in 72 weeks
In Sweden, Mounjaro is approved for obesity, but pricing is still high and it is not reimbursed
The SUSTAIN 8 study showed lean mass decreased 2.3 kg alongside total weight loss of 5.3 kg
Certificate of Analysis Batch-specific third-party lab results included with every order
References Geisler CE, Antonellis MP, Trumbauer W, et al
US$ 28.74
US$ 22.74
US$ 27.33
US$ 24.00
US$ 21.63
US$ 22.76
US$ 27.89
US$ 28.91
